wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26738986-ABC8C94A-88A8-444D-A463-F5970DB6C09B
Q26738986-ABC8C94A-88A8-444D-A463-F5970DB6C09B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738986-ABC8C94A-88A8-444D-A463-F5970DB6C09B
Targeted therapies and immunotherapy in non-small-cell lung cancer
P2860
Q26738986-ABC8C94A-88A8-444D-A463-F5970DB6C09B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738986-ABC8C94A-88A8-444D-A463-F5970DB6C09B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2aec14f17f5ecb241c82456e4389b856c44be659
P2860
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study.